PL1814907T3 - Zestaw części zaprojektowany do przeprowadzania leczenia przeciwnowotworowego lub przeciwwirusowego u ssaka - Google Patents

Zestaw części zaprojektowany do przeprowadzania leczenia przeciwnowotworowego lub przeciwwirusowego u ssaka

Info

Publication number
PL1814907T3
PL1814907T3 PL05802308T PL05802308T PL1814907T3 PL 1814907 T3 PL1814907 T3 PL 1814907T3 PL 05802308 T PL05802308 T PL 05802308T PL 05802308 T PL05802308 T PL 05802308T PL 1814907 T3 PL1814907 T3 PL 1814907T3
Authority
PL
Poland
Prior art keywords
kit
antitumoral
mammal
implementing
antiviral treatment
Prior art date
Application number
PL05802308T
Other languages
English (en)
Inventor
Philippe Erbs
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of PL1814907T3 publication Critical patent/PL1814907T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
PL05802308T 2004-11-08 2005-10-26 Zestaw części zaprojektowany do przeprowadzania leczenia przeciwnowotworowego lub przeciwwirusowego u ssaka PL1814907T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04360101 2004-11-08
US64659505P 2005-01-26 2005-01-26
PCT/IB2005/003435 WO2006048768A2 (en) 2004-11-08 2005-10-26 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
EP05802308A EP1814907B1 (en) 2004-11-08 2005-10-26 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal

Publications (1)

Publication Number Publication Date
PL1814907T3 true PL1814907T3 (pl) 2009-07-31

Family

ID=35539415

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05802308T PL1814907T3 (pl) 2004-11-08 2005-10-26 Zestaw części zaprojektowany do przeprowadzania leczenia przeciwnowotworowego lub przeciwwirusowego u ssaka

Country Status (17)

Country Link
US (1) US8470591B2 (pl)
EP (1) EP1814907B1 (pl)
JP (2) JP5372374B2 (pl)
KR (1) KR101134185B1 (pl)
CN (1) CN101072792B (pl)
AT (1) ATE421534T1 (pl)
AU (1) AU2005300248B2 (pl)
CA (1) CA2584681C (pl)
CY (1) CY1109850T1 (pl)
DE (1) DE602005012535D1 (pl)
DK (1) DK1814907T3 (pl)
ES (1) ES2320157T3 (pl)
IL (1) IL183015A (pl)
MX (1) MX2007005474A (pl)
PL (1) PL1814907T3 (pl)
PT (1) PT1814907E (pl)
WO (1) WO2006048768A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2136631E (pt) 2007-04-14 2012-09-27 Southern Res Inst Processos para tratamento da neoplasia com associação de agentes quimioterapêuticos e radiação
US9687515B2 (en) 2007-11-19 2017-06-27 Transgene S.A. Poxviral oncolytic vectors
CA2770075C (en) 2009-08-07 2021-08-24 Perrine Martin Composition for treating hbv infection
TW201221063A (en) * 2010-12-13 2012-06-01 Tai-Song Guo Enzyme-assisting yeast, enzyme dough, brewed dough and method of brewing bread, baozi, mantou, bagel and unique enzyme thereof
KR102457060B1 (ko) 2014-04-10 2022-10-19 트랜스진 폭스바이러스 종양용해 벡터
JP6731646B2 (ja) * 2016-07-13 2020-07-29 国立大学法人鳥取大学 外来遺伝子発現ワクシニアウイルスの製造方法
WO2018091680A1 (en) 2016-11-18 2018-05-24 Transgene Sa Cowpox-based oncolytic vectors
US20200032249A1 (en) * 2017-03-14 2020-01-30 Memorial Sloan Kettering Cancer Center Labeling, isolation, & analysis of rna from rare cell populations
CN111826393B (zh) * 2020-08-04 2022-02-08 湖南农业大学 一种同时调控水稻粒型粒重和抗性的基因及其编码蛋白的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856153A (en) * 1994-11-17 1999-01-05 Cayla Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases
US5858707A (en) * 1995-07-05 1999-01-12 Schering Corporation Purified mammalian nucleobase permeases; nucleic acids; antibodies
US6153740A (en) * 1995-07-07 2000-11-28 University Of Alberta cDNA encoding nucleoside transporter
US6749863B1 (en) * 1997-11-19 2004-06-15 Georgetown University Targeted liposome gene delivery
FR2777570A1 (fr) * 1998-04-17 1999-10-22 Transgene Sa Mutant ayant une activite phosphoribosyl transferase
US6552005B1 (en) * 1998-09-29 2003-04-22 Uab Research Foundation Molecular chemotherapy enhancement of radiotherapy
FR2794025A1 (fr) * 1999-05-25 2000-12-01 Transgene Sa Composition destinee a la mise en oeuvre d'un traitement antitumoral ou antiviral chez un mammifere

Also Published As

Publication number Publication date
CN101072792B (zh) 2012-09-26
DE602005012535D1 (de) 2009-03-12
PT1814907E (pt) 2009-03-27
KR101134185B1 (ko) 2012-04-09
MX2007005474A (es) 2007-07-10
CY1109850T1 (el) 2014-09-10
AU2005300248B2 (en) 2012-04-26
CA2584681A1 (en) 2006-05-11
IL183015A0 (en) 2007-09-20
CA2584681C (en) 2014-05-13
DK1814907T3 (da) 2009-05-18
AU2005300248A1 (en) 2006-05-11
JP5372374B2 (ja) 2013-12-18
WO2006048768A2 (en) 2006-05-11
JP2013209415A (ja) 2013-10-10
KR20070091614A (ko) 2007-09-11
CN101072792A (zh) 2007-11-14
JP2008519024A (ja) 2008-06-05
WO2006048768A8 (en) 2007-06-14
IL183015A (en) 2012-02-29
EP1814907B1 (en) 2009-01-21
US8470591B2 (en) 2013-06-25
ES2320157T3 (es) 2009-05-19
ATE421534T1 (de) 2009-02-15
EP1814907A2 (en) 2007-08-08
HK1107360A1 (en) 2008-04-03
US20090170795A1 (en) 2009-07-02
WO2006048768A3 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
IL183015A0 (en) Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
JO3076B1 (ar) نظم العلاج المناعي المعتمد على حالة apoe
TW200700433A (en) Acylated glp-1 compounds
UA93653C2 (ru) Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r)
IL181238A (en) Sirna molecules to inhibit rtp801 gene expression and their medical use
IL190331A0 (en) Deuterated inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties
MX2018008440A (es) Vectores de terapia genica y citosina deaminasas.
IL189555A0 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
IL200151A (en) Preparations containing nucleic acid coded for il-10, il-4, and tgfbeta for the treatment of Alzheimer's disease
TW200611910A (en) Interferon-alpha polypeptides and conjugates
IL187079A (en) OligoAdenylate Synthetic Protein 1, Pharmaceutical Preparations Containing and Using It
IL174787A0 (en) Use of cell lines to produce active therapeutic proteins
GB0418388D0 (en) Cell therapy
PL376343A1 (pl) Modyfikowane zrekombinowane komórki (ARC) do wytwarzania i dostarczania środków przeciwwirusowych, adiuwantów i przyspieszaczy szczepionek
PL2046394T3 (pl) Zastosowanie sekwencji kwasów nukleinowych do leczenia chorób neurologicznych i psychiatrycznych, wektory i kompozycje
IL169367A0 (en) Defensin proteins
TW200724679A (en) Treatment of disease using an improved regulated expression system
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
GB201018125D0 (en) Peptide
WO2003092736A3 (en) Peptide nucleic acid conjugates with transporter peptides
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
EP1828237A4 (en) HUMAN CANCER SUPPRESSOR GENE, PROTEIN ENCODED THEREIN, EXPRESSION VECTOR CONTAINING THE GENE, AND CELL TRANSFORMED BY THE VECTOR
WO2006016172A3 (en) Cell surface glycoprotein
IL174645A0 (en) MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein